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Summary Disseminated disease caused by non-tuberculous, environmental mycobacteria (EM)
reflects impaired host immunity. Disseminated disease caused by Mycobacterium scrofulaceum
has primarily been reported in patients with AIDS. Moreover, observing M. scrofulaceum as the
agent of localized disease in childhood has become increasingly rare. We report the first case of
disseminated disease caused byM. scrofulaceum in a child with inherited interferon-g receptor 1
(IFN-gR1) complete deficiency. As in this case, mycobacterial bone infections in IFN-gR1
deficiency can sometimes mimic the clinical picture of chronic recurrent multifocal osteomye-
litis.
# 2009 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.Introduction
Mycobacterium scrofulaceum is one of the best known myco-
bacterial species, and was described almost 50 years ago.1* Corresponding author. Tel.: +39 010 5636260/340;
fax: +39 010 384323.
E-mail address: mgmarazzi@ospedale-gaslini.ge.it
(M.G. Marazzi).
1201-9712/$36.00 # 2009 Published by Elsevier Ltd on behalf of Intern
doi:10.1016/j.ijid.2009.03.025Traditional microbiology describes M. scrofulaceum as a slow
growing scotochromogenic species that is characterized by
negativity of almost all the most frequently performed bio-
chemical tests, but showing consistently positive catalase
assays. The most popular phylogenetic school, which is based
on the nucleotide sequence of the gene encoding the 16S
rDNA, places M. scrofulaceum in an isolated evolutionary
branch not closely related to any other species. This classi-
fication likely reflects the unique sequence of M. scroful-
aceum in helix 18, which is characterized by the presence of aational Society for Infectious Diseases.
Figure 1 X-ray of the legs: mixed bilateral alteration of the
bone structure of the tibial diaphysis (arrows).
e168 M.G. Marazzi et al.9-nucleotide insertion that differentiates M. scrofulaceum
from slow growers (presenting a 12-nucleotide insertion) and
from rapid growers (lacking any insertion).2
The name M. scrofulaceum derives from ‘scrofula’, an
infection of the cervical lymph nodes. It refers to the high
frequency with which this species is found in such lesions in
pre-school children.3 Recently, however, isolating M. scro-
fulaceum in childhood lymphadenitis has become increas-
ingly rare, while the incidence of other non-tuberculous,
environmental mycobacteria (EM), especially Mycobacter-
ium avium and several newly identified species, has
increased.2,3 Far less commonly observed clinical manifesta-
tions of M. scrofulaceum infection in adults include pulmon-
ary disease,4 osteomyelitis,5 hepatitis,6 and disseminated
disease,7,8 primarily in AIDS patients,9 while intrathoracic
and, more rarely, disseminated disease are reported in chil-
dren.10,11
To the best of our knowledge, no cases of disseminated
disease caused byM. scrofulaceum have been reported in any
patients at all with primary immunodeficiency, except in a
patient with a dominant interferon-g (IFN-g) receptor defi-
ciency.12
Case report
An Italian boy, aged 2 years and 10 months, was admitted to a
local hospital because of fever and pain in his right leg, right
foot, and left hand. His parents were born in the same small
town, yet consanguinity was not documented. The child had
not been inoculated with bacille Calmette—Gue´rin (BCG). On
admission, the patient appeared to be in a severe clinical
condition: his weight and height were under the 5th percen-
tile, and laboratory tests revealed severe hypochromic ane-
mia, thrombocytosis, leukocytosis, and elevated
inflammatory indices. Morphological bone marrow examina-
tion ruled out leukemia, and radiological studies showed
multiple disseminated osteolytic lesions. Bone biopsy showed
paratrabecular fibrosis, partial lamellar resorption with no
signs of necrosis. Unfortunately, bone biopsy culture was not
performed. Intravenous antibiotics (ceftriaxone, amikacin,
teicoplanin for 18 days) and non-steroidal anti-inflammatory
drugs led to a transient improvement in pain, and the patient
was discharged with a diagnosis of suspected chronic recur-
rent multifocal osteomyelitis.
Three months later, the child was referred to our institute
because of persistent abdominal pain, limb pain, and gait
problems. He was in a poor general condition with persistent
fever. Laboratory tests showed severe anemia (hemoglobin
6.3 g/dl), leukocytosis (52.92  109/l), thrombocytosis (pla-
telets 1065  109/l), and elevated inflammatory markers.
The results of immunological testing (serum levels of immu-
noglobulins, peripheral B and T lymphocytes, CD4/CD8 sub-
set, complement) were normal. Chronic granulomatous
disease was ruled out. Serological tests for Borrelia burgdor-
feri, Bartonella henselae, Yersinia enterocolitica, and Yersi-
nia pseudotuberculosis, toxoplasmosis, cytomegalovirus,
and HIV infection were negative. A Mantoux test was 5 mm
after 48 hours and negative after 72 hours. Bone marrow
biopsy was negative.
Radiological study of the hands and legs showed an altera-
tion of the bone structure (Figure 1). Magnetic resonance
imaging (MRI) of the legs, feet, and hands showed multiplefocal lesions of the medullary region with metaphyseal,
epiphyseal, and diaphyseal involvement of the long bones
(Figure 2). A computed tomography (CT) scan of the abdomen
revealed a hypodense lesion in the left lobe of the liver and
enlarged mesenteric and peripancreatic lymph nodes. A
mesenteric lymph node biopsy was performed because of
suspected histiocytosis, and histological examination
revealed ‘granulomatous necrotizing lymphadenitis’. A pre-
valent neutrophilic infiltration associated with histiomacro-
phagic reaction was observed, while no epithelioid cells or
giant Langhans multinucleated cells were found (Figure 3).
Acid-fast rods were visible in the biopsy specimens. Culturing
the lymph node yielded acid-fast bacilli. Anti-tuberculous
therapy with isoniazid, rifampin, ethambutol, pyrazinamide,
and streptomycin was started. As soon as rifabutin- and
clarithromycin-sensitive M. scrofulaceum was identified,
treatment with rifampin, rifabutin, and clarithromycin was
started. The child improved andMRI showed no progression of
bone lesions. This therapy was continued for ten months.
Three months after therapy was discontinued, the patient
presented recurrence of high fever, severe pain, and swelling
of the hands and feet, and was re-admitted to our unit. The
child was unable to walk, and enlarged lymph nodes at the
popliteal and epitrochlear sites were evident. An MRI scan of
the legs revealed diffuse alterations of the signal, involving
Figure 2 MRI T1-weighted sequences: multiple focal lesions of
the medullar region involving the long bones of the legs (arrows).
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of the pelvis. A biopsy of the epitrochlear and popliteal lymph
nodes was performed and histological examination revealed
numerous acid-fast bacilli in both samples. Culture was
positive for M. scrofulaceum. Disseminated M. scrofulaceum
infection was diagnosed on the basis of the recurrence of the
same mycobacterial infection (positive culture from variousFigure 3 Mesenteric lymph node biopsy: altered structure
with neutrophilic infiltration associated with histiomacrophagic
reaction. The Ziehl—Neelsen coloration highlights the presence
of numerous acid-alcohol resistant bacilli in the cytoplasm of the
histiocytes (100  ).lymph node biopsies), the child’s severe clinical condition
(multiple bone lesions), and the good response to specific
antibiotic therapy.
Diagnostic evaluation of the IFN-g/interleukin-12
(IL-12) axis
We then suspected a defect of innate immunity, thus IFN-g/
IL-12 axis defects were investigated. An ex vivo whole blood
assay showed a complete defect of response to BCG and
BCG + IFN-g stimulation in terms of IL-12p40 and IL-12p70
production and only a mild defect of response to BCG and
BCG + IL-12 in terms of IFN-g production, as can be observed
in patients with complete IFN-g receptor deficiencies (data
not shown). Genes of the IFN-g pathway were then
sequenced and homozygous deletion of a thymidine was
found in exon 4 at the genomic level and at position 523
at the cDNA level in the IFN-g receptor 1 (IFN-gR1) gene (data
not shown). The 523delT mutation leads to a premature stop
codon at position 526—528. It is associated with a complete
defect of IFN-gR1 expression and function and is inherited in
an autosomal recessive mode.13 Antimycobacterial therapy
was resumed and the patient was discharged on therapy with
streptomycin, clarithromycin, rifabutin, and ethambutol.
Subsequently, the patient was examined every month and
his general clinical condition slowly improved. A radiographic
study of the legs showed an improvement in the previous
diffuse lesions. Six months after discharge, we treated the
child with acyclovir due to a contact with an individual
affected by chickenpox. The patient did not develop the
disease, but anti-varicella zoster virus antibodies were
detected in his serum. Currently, the child is in a good, stable
clinical condition and is continuing home therapy with clar-
ithromycin, rifabutin, and moxifloxacin in the absence of any
signs of EM infection.
Microbiology
Identification was carried out on two different strains that
were isolated 14 months apart. The first strain was isolated
from a mesenteric lymph node and the second one from a
popliteal lymph node. In both cases, a commercial line probe
assay (INNO LiPA, Innogenetics, Belgium)14 unquestionably
assigned the organism to the M. scrofulaceum species. Very
recently, however, a study pointed out that by using com-
mercial DNA probes, the hybridization results of a newly
described species, i.e., Mycobacterium parascrofulaceum,15
are undistinguishable from M. scrofulaceum results.16 To
verify the correctness of our results, we decided to retrieve
one of the two frozen strains and to determine the genetic
sequence of the 50 end of the 16S rDNA. The sequence turned
out to be 100% identical to the M. scrofulaceum strain
sequence that had been deposited in GenBank.
Susceptibility testingwas performed on both strains using
the macrodilution method in radiometric broth.17 The two
strains appeared to be resistant to amikacin and ciproflox-
acin, but were susceptible to rifabutin. Both rifampin and
streptomycin appeared to bemoderately active. The former
strain was susceptible and moderately susceptible to clar-
ithromycin and ethambutol, respectively, while the second
strain was moderately susceptible and fully resistant,
respectively.
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Disseminated disease caused by EM reflects impaired host
immunity, as illustrated in patients with AIDS.9 There are also
primary immunodeficiencies associated with disseminated
EM infection in young children, albeit very rarely;18 inherited
disorders of the IL-12/IFN-g circuit are more frequent.19,20
Severe clinical disease caused by EM M. scrofulaceum in our
patient thus prompted us to search for defects in the IL-12/
IFN-g circuit. As in this case, mycobacterial bone infections in
IFN-gR1 deficiency can sometimes mimic the clinical picture
of chronic recurrent multifocal osteomyelitis.21 To our knowl-
edge, this is the first case of disseminated disease caused by
M. scrofulaceum in a child with a complete IFN-gR1 defi-
ciency.
Complete IFN-gR1 deficiency is autosomal recessive and
is associated with complete absence of cell responsiveness
to IFN-g.19,20 This absence is characteristically associated
with severe disseminated mycobacterial infection that may
involve the lungs, spleen, liver, lymph nodes, blood, central
nervous system, and bones.22 Onset of acquired mycobac-
terial infection often occurs before 3 years of age. Infections
are typically caused either by EM species acquired from
environmental exposure, or by Mycobacterium bovis or
BCG acquired through vaccination.22,23 These patients have
chronic disease that does not disappear with treatment and
that relapses after discontinuing antibiotics. The survival
rate is low and 55% of themdie before 10 years of age.22 Bone
marrow transplantation should be considered in complete
IFN-gR1 deficiency.24 A recent study showed that the pre-
valence of mycobacterial disease in patients with IFN-gR1
deficiency was 95% and that the M. avium complex was the
most commonly isolated mycobacterial pathogen. Over-
whelming infection with Mycobacterium tuberculosis has
also been microbiologically confirmed in a patient already
infected with Mycobacterium fortuitum and with complete
recessive IFN-gR1 deficiency.22 Disseminated infection with
rapidly growing mycobacteria, such as Mycobacterium
smegmatis and Mycobacterium peregrinum, has been
reported.14,25 The present case provides additional evi-
dence that a diagnosis of IFN-gR1 or IFN-gR2 deficiency
should be taken into consideration in all childrenwith severe
EM disease.
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